Bicarbonate

Bicarbonate

SCHEMBL360784

O=C(O)O.O=C(O)O.O=C(O)O.O=C(O)O.O=C(O)O.[CsH].[CsH].[CsH]

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.83
CA2 P00918 1/20 0.83
CA9 Q16790 1/20 0.83
TSHR P16473 4/20 0.50
EGLN1 Q9GZT9 2/20 0.50
TP53 P04637 1/20 0.50
EGLN3 Q9H6Z9 1/20 0.50
FFAR3 O14843 2/20 0.44
ACHE P22303 1/20 0.44
LCK P06239 1/20 0.44
FYN P06241 1/20 0.44
LMNA P02545 3/20 0.36
LDHA P00338 2/20 0.36
LDHB P07195 1/20 0.36
SRR Q9GZT4 1/20 0.36
ALKBH5 Q6P6C2 1/20 0.36
SUCNR1 Q9BXA5 1/20 0.36
OR51E2 Q9H255 2/20 0.33
GLRA1 P23415 1/20 0.33
SLC6A9 P48067 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL1697623 1.00
Bicarbonate SCHEMBL4760181 1.00 CA1 (0.83) CA1CA2CA9TSHREGLN1
Bicarbonate SCHEMBL1931 1.00
Bicarbonate SCHEMBL6182147 0.93
Bicarbonate SCHEMBL6068754 0.93
Bicarbonate SCHEMBL19328229 0.93 CA1 (0.71) CA1CA2CA9TSHREGLN1
Bicarbonate SCHEMBL2356640 0.93
Bicarbonate SCHEMBL21177398 0.93 CA1 (0.71) CA1CA2CA9TSHREGLN1
Bicarbonate SCHEMBL2944491 0.93 CA1 (0.71) CA1CA2CA9TSHREGLN1
Bicarbonate SCHEMBL28594224 0.93 CA1 (0.71) CA1CA2CA9TSHREGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007758-A2 PHARMACEUTICAL FORMULATIONS ASTRAZENECA AB (SE) 2012-01-19 WO disclosed
EP-2396314-A1 PROCESS FOR PREPARATION OF BEZOYL AMINO HETEROCYCLYL COMPOUNDS AstraZeneca AB (SE) 2011-12-21 EP disclosed
EP-2396317-A1 CRYSTALLINE POLYMORPHIC FORM 631 AstraZeneca AB (SE) 2011-12-21 EP disclosed
WO-2010092387-A1 PROCESS FOR PREPARATION OF BEZOYL AMINO HETEROCYCLYL COMPOUNDS ASTRAZENECA AB (SE) 2010-08-19 WO disclosed
WO-2010092386-A1 CRYSTALLINE POLYMORPHIC FORM 631 ASTRAZENECA AB (SE) 2010-08-19 WO disclosed